A Multicenter, Open-label, Phase 1b/2 Study of HC-5404 and Tivozanib in Patients with Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)
Study#: SCRI 26059 (PENDING)
Contact Us: For information about this clinical study, Email Us.
Our practice complies with the Office for Civil Rights and does not discriminate based on race, color, national origin, sex, age or disability. View the notice by clicking here.
Comprehensive Cancer Centers of Nevada is helping patients by providing state-of-the-art treatment through clinical research studies. Learn More.
